-
Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Bardani E, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:408-415. pdf -
Genome-wide cfDNA testing of maternal blood.
Jani JC, Gil MM, Benachi A, Prefumo F, Kagan KO, Tabor A, Bilardo CM, Di Renzo GC, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:13-14. pdf -
First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P, Wright A, Syngelaki A, Konstantinidou L, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:326-331. pdf -
Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.
Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:338-41. -
Fetal megacystis at 10-14 weeks of gestation.
Sebire NJ, Von Kaisenberg C, Rubio C, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;8:387-90. -
Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation.
Snijders RJ, Sebire NJ, Faria M, Patel F, Nicolaides KH.
Fetal Diagn Ther 1995;10:349-55.